Skip to main content
search
Tag

Advocacy Archives - Neurosurgery Blog

Cross-Post: Patient Advocacy in Neurosurgery

By Access to Care, Cross PostNo Comments

From time to time on Neurosurgery Blog, you will see us cross-post articles that we believe are of interest to our readers. Today’s post comes from a recent article in the AANS Neurosurgeon, the official socioeconomic publication of the American Association of Neurological Surgeons (AANS). In the article, Sarah I. Woodrow, MD, FAANS, outlines the importance of patient advocacy in neurosurgery and lists opportunities for neurosurgeons to get involved.

“Physician advocacy should be part of the daily practice of all neurosurgeons. Many of us advocate for our patients routinely as we participate in their care. It is important, however, to think beyond the needs of an individual patient and engage in system-level advocacy to promote a larger concept of societal well-being,” according to Dr. Woodrow. Opportunities include:

  • Working locally within one’s own health care system or organization to improve access and quality of care to patients, particularly those whose care has traditionally been neglected.
  • Interacting with local media to draw attention to issues faced by patients.
  • Engaging with local or national special interest groups (e.g., ThinkFirst, National Brain Tumor Society and Hydrocephalus Association) to promote ideas such as awareness or disease prevention.
  • Collaborating with colleagues at state neurosurgery medical societies and engaging with the Council of State Neurosurgical Societies — whose role in organized neurosurgery focuses on socioeconomic policy impacting neurosurgery practice and the quality of care delivered to our patients.
  • Engaging with state or federal lawmakers to advocate for legislation and policies that promote equitable health and safety for all.
  • Supporting the AANS/Congress of Neurological Surgeons Washington Committee and the Washington Office, the voice of organized neurosurgery at the national level. The committee, comprised of a cross-section of neurosurgeons, oversees neurosurgery’s health policy and advocacy efforts.
  • Donating to NeurosurgeryPAC, the non-partisan political action committee of the AANS that makes campaign contributions to political candidates that support issues important to neurosurgery.

For neurosurgeons interested in strengthening their role as physician advocates, starting small and local may seem like the best option. For others, organized neurosurgery has numerous opportunities to affect systemic change. Regardless of the approach, Dr. Woodrow notes that neurosurgeons must never underestimate the power of their voice to advocate for patients.

Click here to read the full article in the AANS Neurosurgeon.

Editor’s Note: We hope you will share what you learn from our posts. We invite you to join the conversation on Twitter by following @Neurosurgery and @AANSNeurosurg.

July 22, 2022
Love1

Improving the Field of Neurosurgery through Brain Tumor Advocacy

By Brain Tumor, Tumor, Tumor Series, White HouseNo Comments

Working with patient advocates is important for neurosurgeons and neurosurgeons in training. While neurosurgeons help patients through clinical work and conduct innovative research to advance treatment options, advocacy can have an outsized impact on patients across the U.S. Neurosurgeons who participate in patient advocacy gain a better understanding of the priorities of patients, their families and those who care about them.

As a member of the National Brain Tumor Society (NBTS) board of directors, I have had the opportunity to better understand the concerns and priorities of patients dealing with brain tumors and their caregivers. This helps me educate the broader patient population about brain tumor neurosurgery, clinical trials and what my institution offers. NBTS, its Informed in 30 educational program and virtual meetings with brain tumor community members have changed how I communicate with patients, including discussing treatment options and clinical trials. I have learned a great deal about how I can become a better neurosurgeon and think we would all benefit from such education, thus improving our delivery of patient care.

Patient advocacy can do much more than an individual neurosurgeon scientist can to attract research funds to the field. As an individual, I can only apply for so many grants. Patient advocates, tapping into the power of patient stories, can influence lawmakers, friends and families to provide funding for research to benefit the field of neurosurgery and neuro-oncology. NBTS annually disburses approximately $2 million to researchers from across the country. By participating in this process, I can have a hand in steering the direction of not just my lab but that of researchers across the country. In this way, I can encourage rigorous and innovative research that acknowledges the reality of this challenging disease and promote the critical need for neurosurgeons to be involved in clinical trials.

Patient advocate groups like NBTS can have an outsized impact on public policy and, importantly, serve as a platform for patients, caregivers and brain cancer medical providers to have a voice on critical issues facing our cause to ultimately eliminate these diseases and reduce disease burden. While I can call my senator as an individual to advocate for policy changes needed for our field, a group like NBTS has the resources necessary to make long-term relationships with lawmakers across the country, raising the critical needs of their constituents. Like the AANS/CNS Washington Committee, NBTS understands the needs of its volunteers and advocates. They combine the power of all of these individuals to encourage our representatives in Washington to address our concerns.

Every year, NBTS holds the Head To The Hill event (#Head2Hill), where brain tumor patient advocates descend upon Washington, DC, in person or virtually, to present a united front on key issues for the community. While increased federal research funding is a priority every year, directly impacting neurosurgeon-scientists, this year, NBTS also focused on extending telemedicine rules created during the COVID-19 pandemic. I participated in Head to the Hill in May. It was a wonderful experience working side by side with other brain tumor advocates from Georgia on these critical issues. Additionally, through NBTS’s Research Roundtable Program, I have been able to bring expertise to regulatory policy with the Food and Drug Administration in workshops and meetings on clinical trial design and endpoints.

Patient advocacy can also lead to rewarding and one-of-a-kind opportunities in one’s career. An exciting example is my recent opportunity to introduce President Joseph R. Biden, Jr. to unveil the extension of the Cancer Moonshot initiative. This initiative was established in 2016 by then-President Barack Obama to support cancer research and progress in treatment and care.

At its launch, the Cancer Moonshot set forth three ambitious goals: accelerate scientific discovery in cancer, foster greater collaboration, and improve data sharing. On Feb. 2, President Biden announced additional steps to “reignite” the Cancer Moonshot initiative to “ending cancer as we know it” by halving the number of cancer deaths in the U.S. in the next 25 years. Leaders from NBTS had a hand in crafting the initial Cancer Moonshot and sat with me at this prestigious event. Together, I am confident we will make real change for the brain tumor community and someday find a cure and better quality of life for our patients.

I would strongly encourage other neurosurgeons to establish relationships with patient advocates in their fields. My time working with NBTS has been an invaluable tool to improve the patient care that I deliver, improve research in the area of brain tumors and have a direct impact on public policy.

Editor’s Note: We hope that you will share what you learn from our posts. We invite you to join the conversation on Twitter by following @Neurosurgery and @NSTumorSection and using the hashtag #TumorSeries.

Edjah K. E. Nduom, MD, FAANS
Emory University School of Medicine, Department of Neurosurgery
Atlanta, Ga.

May 27, 2022
Love0